HomeAbout Graceway
Mission StatementCompany HistoryLeadership TeamLocationsComprehensive Compliance Program
Our Products
Dermatology   Aldara   Atopiclair   BenziqRespiratory   Maxair AutohalerWomen's Health   EstrasorbAll Products
Conditions We Treat
Dermatology   Actinic keratosis   Superficial basal cell carcinoma   External genital warts   Atopic dermatitis   AcneRespiratory   Asthma
Business OpportunitiesCareersNewsContact 
 

Introducing Graceway Pharmaceuticals, LLC

Founded with a culture of commitment to physicians and patients, Graceway Pharmaceuticals is dedicated to enhancing the quality of health care. By delivering both trusted products and innovative new therapies, Graceway is defining itself as an inspired source for advanced medicines.

Bringing Science to Life

The scientific and technological innovations that advance medicine hold vast promise for improving the quality of life for patients. Graceway is dedicated to bringing the medical community advanced products with unique benefits, enabling health care professionals to better help patients live healthier lives.

NASCAR corporate sponsorship

Graceway Pharmaceuticals sponsors Billy Ballew Motorsports entries in the NASCAR Camping World Truck Series for the remainder of the 2009 season.

Learn more about Graceway drivers and races
Graceway proudly welcomes Aldara to our family of products

Graceway Pharmaceuticals acquired Aldara from 3M Pharmaceuticals in December 2006. Aldara offers patients a topical treatment alternative to several serious skin diseases that may otherwise require surgical treatment.

Learn more about Aldara
hello
Other Graceway Sites:
CANADA
MEXICO
LATIN AMERICA
 
 News Headlines

Bristol, TN  November 6, 2009

Graceway Pharmaceuticals Acquires Worldwide Rights to GS 9191 from Gilead Sciences

Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, today announced ...

>>Read more

Bristol, TN  July 31, 2009

Data Demonstrate New Imiquimod Formulation as Short Course Treatment for Actinic Keratosis

FDA Accepts NDA for New Imiquimod Product ...

>>Read more

New York, NY  July 1, 2009

Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer

Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, and Pfizer Inc. (NYSE: PFE) today announced ...

>>Read more

Bristol, TN  May 29, 2008

Study in Journal of Pediatrics

ATOPICLAIR® is Effective Monotherapy for Mild to Moderate Atopic Dermatitis in Infants and Children ...

>>Read more

Bristol, TN  April 21, 2008

Study in New England Journal of Medicine

ALDARA® (imiquimod) Cream, 5% demonstrated a reduction in lesion size in patients with vulvar intraepithelial neoplasia (VIN) ...

>>Read more

Bristol, TN  April 16, 2008

Study in British Journal of Dermatology

Patients Treated with ALDARA Experienced Higher Levels of Histological and Sustained Clearance for Actinic Keratosis than Patients in two Other Common AK Treatments ...

>>Read more

 

Use of this website is governed by our Terms of Use and Privacy Policy © 2008 Graceway Pharmaceuticals, LLC
The product information provided in this site is intended only for residents of the United States.
The products discussed herein may have different product labeling in different countries.